PACB - PacBio reports prelim Q4 revenue of $58.4M shares fall
2024-01-08 10:59:39 ET
More on Pacific Biosciences of California
- Pacific Biosciences' Revio And Onso Lead Looks Priced In For Now
- Reassessing Pacific Biosciences: Deep Dive Into Q3 2023 Revenue Surge And Market Dynamics
- Pacific Biosciences of California Q3 2023 Earnings Call Transcript
- Pacific Biosciences of California rises after UBS upgrades on strong 'Revio' demand
For further details see:
PacBio reports prelim Q4 revenue of $58.4M, shares fall